AccuPlex™ Technology for Rapid Development of Molecular Diagnostic Assays in Response to Viral Infectious Diseases
IVD developers and manufacturers agree that the most effective reference materials for infectious disease assays are full-process, non-infectious, and available in large quantities within a short time frame.
This white paper details how AccuPlex recombinant virus technology enables replication-defective virus particles that are commutable in any sample matrix and closely mimic pathogenic virus found in clinical samples.
Download this white paper to learn:
- Why AccuPlex reference materials can serve as full‑process controls, positive controls, and internal controls
- How AccuPlex reference materials were deployed to fight the 2014 Ebola crisis and today's Zika outbreak
- What enables AccuPlex recombinant virus to accommodate large target sequence for highly multiplexed assays while remaining safe to handle